DUBLIN, April 23, 2013 /PRNewswire/ --
Research and Markets has announced the addition of the "Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] Global Forecasts to 2017" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces its history to more than 2,000 years ago, when Romans, Chinese and Aztecs used gold for dental applications. Biomaterials, which are also biocompatible, have since been adapted, improvised, and technically enabled to improve body functions and replace damaged tissues. They have evolved to include biodegradable materials that are easily dissolved in the body. Advances in technology and the emergence of innovative biomaterial products have enhanced their performance and applications.
The global biomaterial market is estimated to reach $88.4 billion by 2017 from $44.0 billion in 2012, growing at a CAGR of 15%. Increased investments, funding and grants by government bodies worldwide, an incessant rise in the number of collaborations, conferences and research-related activities, technological advancements, increasing applications of biomaterials, and a growing number of elderly people are the major factors propelling the growth of the biomaterial market globally. Immunological and inflammatory reactions, stringent regulatory systems, issue of fracture fatigue and wear and reimbursement concerns are the major deterrents curbing the biomaterial market.
The global biomaterial market witnesses a plethora of growth opportunities. Novel developments of biomaterial for wound healing, plastic surgery, tissue engineering, ophthalmology, and neurology, a colossal pool of cardiac patients in Asia, the rise of the biomaterial market in China and Taiwan, and increased conferences and research-related activities in RoW countries are major factors influencing the growth of the biomaterial market. The burning issues affecting the growth of the biomaterial market are challenges to tissue engineering and effect on suppliers by the Biomaterials Access Assurance Act.
This research report categorizes and analyzes the global biomaterial market under two broad segments: type and application. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.
Please click here to view a sample of this report
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Biomaterial Market, by Type
5 Global Biomaterial Market, by Application
6 Geographic Analysis
7 Competitive Landscape
8 Company Profiles
Companies Mentioned - for a full list, please click here.
- Basf Se
- Bayer Ag
- Biomet, Inc.
- Cam Bioceramics Bv
- Collagen Natrix, Inc.
- Covalon Technologies Ltd.
- Dentsply International, Inc.
- Depuy Orthopaedics, Inc.
- Hycail Finland Oy
- Invibio Ltd.
- Kyocera Corporation
- Landec Corporation
- Materion Corporation
- Orthovita, Inc.
- Osteotech, Inc.
- Purac Ciomaterials (A Csm Company)
- Sigma-Aldrich Corporation
- Starch Medical, Inc.
- Wright Medical Group, Inc.
For more information visit Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends
SOURCE Research and Markets